A Distinct Subpopulation of Bone Marrow Mesenchymal Stem Cells, Muse Cells, Directly Commit to the Replacement of Liver Components

American Journal of Transplantation

Volumn 16, Issue 2, 2016, Pages 468-483

  Katagiri, H ^a   Kushida, Y ^b   Nojima, M ^b   Kuroda, Y ^b   Wakao, S ^b   Ishida, K ^a   Endo, F ^a   Kume, K ^a   Takahara, T ^a   Nitta, H ^a   Tsuda, H ^c,d   Dezawa, M ^b   Nishizuka, Satoshi S ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL   (Japan)

^d NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

basic (laboratory) research; hepatology; liver transplantation; living donor; regenerative medicine; science; stem cells; translational research

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL DIFFERENTIATION; CELL FUNCTION; CELL LABELING; CELL LINEAGE; CELL SUBPOPULATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KUPFFER CELL; LIVER CELL; LIVER REGENERATION; LIVER TRANSPLANTATION; LIVING DONOR; MOUSE; MULTILINEAGE DIFFERENTIATING STRESS ENDURING CELL; NONHUMAN; PARTIAL HEPATECTOMY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCID MOUSE; STEM CELL TRANSPLANTATION; TISSUE REPAIR; ADULT; ADVERSE EFFECTS; ANIMAL; BONE MARROW TRANSPLANTATION; CHILD; ENZYME IMMUNOASSAY; INSTITUTE FOR CANCER RESEARCH MOUSE; LIVER DISEASES; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; PHYSIOLOGY; POSTOPERATIVE COMPLICATIONS; PROGNOSIS;

ADULT; ANIMALS; BONE MARROW TRANSPLANTATION; CHILD; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION, FLUORESCENCE; LIVER DISEASES; LIVER REGENERATION; LIVER TRANSPLANTATION; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MICE; MICE, INBRED ICR; MICE, SCID; POSTOPERATIVE COMPLICATIONS; PROGNOSIS;

EID: 84957959904     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13537     Document Type: Article

References (35)

1. Aurich I, Mueller LP, Aurich H, et al., Functional integration of hepatocytes derived from human mesenchymal stem cells into mouse livers. Gut 2007; 56: 405-415.
2. Forbes SJ, Newsome PN., New horizons for stem cell therapy in liver disease. J Hepatol 2012; 56: 496-499.
3. Chamberlain G, Fox J, Ashton B, Middleton J., Concise review: Mesenchymal stem cells: Their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 2007; 25: 2739-2749.
4. Pontikoglou C, Deschaseaux F, Sensebe L, Papadaki HA., Bone marrow mesenchymal stem cells: Biological properties and their role in hematopoiesis and hematopoietic stem cell transplantation. Stem Cell Rev 2011; 7: 569-589.
5. Preisegger KH, Factor VM, Fuchsbichler A, Stumptner C, Denk H, Thorgeirsson SS., Atypical ductular proliferation and its inhibition by transforming growth factor beta1 in the 3,5-diethoxycarbonyl-1,4-dihydrocollidine mouse model for chronic alcoholic liver disease. Lab Invest 1999; 79: 103-109.
6. Kuroda Y, Kitada M, Wakao S, et al., Unique multipotent cells in adult human mesenchymal cell populations. Proc Natl Acad Sci U S A 2010; 107: 8639-8643.
7. Iwamoto T, Terai S, Hisanaga T, et al., Bone-marrow-derived cells cultured in serum-free medium reduce liver fibrosis and improve liver function in carbon-tetrachloride-treated cirrhotic mice. Cell Tissue Res 2013; 351: 487-495.
8. Shi C., Recent progress toward understanding the physiological function of bone marrow mesenchymal stem cells. Immunology 2012; 136: 133-138.
9. Wakao S, Kitada M, Kuroda Y, et al., Multilineage-differentiating stress-enduring (Muse) cells are a primary source of induced pluripotent stem cells in human fibroblasts. Proc Natl Acad Sci U S A 2011; 108: 9875-9880.
10. Kinoshita K, Kuno S, Ishimine H, et al., Therapeutic potential of adipose-derived SSEA-3-positive Muse cells for treating diabetic skin ulcers. Stem Cells Transl Med 2015; 4: 146-155.
11. Uchida H, Morita T, Niizuma K, et al., Transplantation of unique subpopulation of fibroblasts, muse cells, ameliorates experimental stroke possibly via robust neuronal differentiation. Stem Cells 2015 (in press)
12. Yamauchi T, Kuroda Y, Morita T, et al., Therapeutic effects of human multilineage-differentiating stress enduring (MUSE) cell transplantation into infarct brain of mice. PLoS One 2015; 10: e0116009.
13. Dezawa M, Kanno H, Hoshino M, et al., Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. J Clin Invest 2004; 113: 1701-1710.
14. Wakao S, Kitada M, Dezawa M., The elite and stochastic model for iPS cell generation: multilineage-differentiating stress enduring (Muse) cells are readily reprogrammable into iPS cells. Cytometry A 2013; 83: 18-26.
15. Pittenger MF, Mackay AM, Beck SC, et al., Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147.
16. Kung C, Pingel JT, Heikinheimo M, et al., Mutations in the tyrosine phosphatase CD45 gene in a child with severe combined immunodeficiency disease. Nat Med 2000; 6: 343-345.
17. Saito T, Deskin RW, Casola A, et al., Respiratory syncytial virus induces selective production of the chemokine RANTES by upper airway epithelial cells. J Infect Dis 1997; 175: 497-504.
18. Atlasi Y, Mowla SJ, Ziaee SA, Gokhale PJ, Andrews PW., OCT4 spliced variants are differentially expressed in human pluripotent and nonpluripotent cells. Stem Cells 2008; 26: 3068-3074.
19. Alcoser SY, Kimmel DJ, Borgel SD, Carter JP, Dougherty KM, Hollingshead MG., Real-time PCR-based assay to quantify the relative amount of human and mouse tissue present in tumor xenografts. BMC Biotechnol 2011; 11: 124.
20. Terada N, Hamazaki T, Oka M, et al., Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 2002; 416: 542-545.
21. Wang X, Willenbring H, Akkari Y, et al., Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature 2003; 422: 897-901.
22. Harris RG, Herzog EL, Bruscia EM, Grove JE, Van Arnam JS, Krause DS., Lack of a fusion requirement for development of bone marrow-derived epithelia. Science 2004; 305: 90-93.
23. Jang YY, Collector MI, Baylin SB, Diehl AM, Sharkis SJ., Hematopoietic stem cells convert into liver cells within days without fusion. Nat Cell Biol 2004; 6: 532-539.
24. Jang YY, Sharkis SJ., Metamorphosis from bone marrow derived primitive stem cells to functional liver cells. Cell Cycle. 2004; 3: 980-982.
25. Sato Y, Araki H, Kato J, et al., Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion. Blood 2005; 106: 756-763.
26. Connick P, Kolappan M, Crawley C, et al., Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: An open-label phase 2a proof-of-concept study. Lancet Neurol 2012; 11: 150-156.
27. Hare JM, Fishman JE, Gerstenblith G, et al., Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: The POSEIDON randomized trial. JAMA 2012; 308: 2369-2379.
28. Le Blanc K, Frassoni F, Ball L, et al., Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: A phase II study. Lancet 2008; 371: 1579-1586.
29. Reinders ME, de Fijter JW, Roelofs H, et al., Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: Results of a phase I study. Stem Cells Transl Med 2013; 2: 107-111.
30. Yin F, Battiwalla M, Ito S, et al., Bone marrow mesenchymal stromal cells to treat tissue damage in allogeneic stem cell transplant recipients: Correlation of biological markers with clinical responses. Stem Cells 2014; 32: 1278-1288.
31. Espejel S, Roll GR, McLaughlin KJ, et al., Induced pluripotent stem cell-derived hepatocytes have the functional and proliferative capabilities needed for liver regeneration in mice. J Clin Invest 2010; 120: 3120-3126.
32. Haridass D, Yuan Q, Becker PD, et al., Repopulation efficiencies of adult hepatocytes, fetal liver progenitor cells, and embryonic stem cell-derived hepatic cells in albumin-promoter-enhancer urokinase-type plasminogen activator mice. Am J Pathol 2009; 175: 1483-1492.
33. Ishikawa T, Banas A, Teratani T, Iwaguro H, Ochiya T., Regenerative cells for transplantation in hepatic failure. Cell Transplant 2012; 21: 387-399.
34. Wakitani S, Okabe T, Horibe S, et al., Safety of autologous bone marrow-derived mesenchymal stem cell transplantation for cartilage repair in 41 patients with 45 joints followed for up to 11 years and 5 months. J Tissue Eng Regen Med 2011; 5: 146-150.
35. Heneidi S, Simerman AA, Keller E, et al. Awakened by cellular stress: Isolation and characterization of a novel population of pluripotent stem cells derived from human adipose tissue. PLoS One 2013; 8: e 64752.